Page last updated: 2024-11-13

neuropeptide y (18-36)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

neuropeptide Y (18-36): amino acid sequence given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71308598
MeSH IDM0166478

Synonyms (8)

Synonym
npy 18-36
114495-97-5
neuropeptide y (18-36)
l-tyrosinamide, l-alanyl-l-arginyl-l-tyrosyl-l-tyrosyl-l-seryl-l-alanyl-l-lenayl-l-arginyl-l-histidyl-l-tyrosyl-l-isolevayl-l-asparginyl-l-leucyl-l-isoleucyl-l-threonyl-l-arginyl-l-glutaminyl-l-arginyl-
98264-90-5
DTXSID90745579
l-alanyl-l-arginyl-l-tyrosyl-l-tyrosyl-l-seryl-l-alanyl-l-leucyl-l-arginyl-l-histidyl-l-tyrosyl-l-isoleucyl-l-asparaginyl-l-leucyl-l-alloisoleucyl-l-threonyl-l-arginyl-l-glutaminyl-l-arginyl-l-tyrosinamide
neuropeptide y(18-36)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Consistent with this observation, the presence of NPY (18-36) (1 microM) shifted the inhibitory adenylate cyclase activity dose-response curve of NPY to the right in a parallel fashion."( Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membranes.
Balasubramaniam, A; Sheriff, S, 1990
)
1.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.00)18.7374
1990's20 (80.00)18.2507
2000's4 (16.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.58 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]